Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,157 | 21,474 | 17,695 | 14,913 | 15,120 |
| Receivables | 122,079 | 132,375 | 130,731 | 129,535 | 123,068 |
| Inventories | 59,402 | 65,490 | 69,898 | 70,711 | 71,702 |
| Other current assets | 10,516 | 6,171 | 5,341 | 4,326 | 5,093 |
| TOTAL | $221,330 | $235,227 | $233,528 | $229,047 | $223,136 |
| Non-Current Assets | |||||
| PPE Net | 97,063 | 97,606 | 98,510 | 98,521 | 99,626 |
| Intangibles | 105,848 | 105,992 | 106,119 | 106,246 | 106,371 |
| Other Non-Current Assets | 160,889 | 161,641 | 159,642 | 154,136 | 157,262 |
| TOTAL | $363,800 | $365,239 | $364,271 | $358,903 | $363,259 |
| Total Assets | $585,130 | $600,466 | $597,799 | $587,950 | $586,395 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,549 | 33,627 | 36,863 | 32,486 | 33,506 |
| Accrued Expenses | 22,901 | 22,281 | 21,972 | 20,178 | 18,791 |
| Other current liabilities | 8,157 | 9,133 | 9,021 | 9,284 | 7,651 |
| TOTAL | $102,445 | $94,938 | $97,598 | $85,468 | $88,097 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126,111 | 139,872 | 147,621 | 160,370 | 163,134 |
| Deferred Revenues | 9,332 | 7,208 | 5,500 | 5,126 | 4,755 |
| Other Non-Current Liabilities | 95,124 | 95,429 | 93,478 | 91,835 | 92,425 |
| TOTAL | $230,367 | $249,107 | $254,507 | $265,065 | $268,491 |
| Total Liabilities | $332,812 | $344,045 | $352,105 | $350,533 | $356,588 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,827 | 46,950 | 46,913 | 46,900 | 46,857 |
| Common Shares | 470 | 469 | 469 | 469 | 469 |
| Retained earnings | 144,862 | 143,346 | 132,070 | 123,508 | 120,756 |
| Other shareholders' equity | 439 | -4 | -324 | -202 | -429 |
| TOTAL | $252,318 | $256,421 | $245,694 | $237,417 | $229,807 |
| Total Liabilities And Equity | $585,130 | $600,466 | $597,799 | $587,950 | $586,395 |